Brief: Ascentage Pharma Group International Posts HY Revenue RMB13.0 Million
24/08/2021 12:18
Aug 24 (Reuters) - Ascentage Pharma Group International
6855.HK :
* HY REVENUE RMB13.0 MILLION VERSUS RMB2.6 MILLION
* HY LOSS RMB376.7 MILLION VERSUS LOSS OF 319.2 MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nHKS8w2fg2
Further company coverage: 6855.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ascentage Pharma International
See all newsBrief: Ascentage Pharma Group Says Lisaftoclax Granted Breakthrough Therapy Designation In China
China's Ascentage Pharma climbs as chairman buys shares on market
Brief: Ascentage Pharma Group International's Chairman Buys 38,630 Shares
Brief: Ascentage Pharma Group International Posts H1 Net Loss Attributable RMB816.7 Million
China's Ascentage Pharma H1 revenue rises 29% on Lisaftoclax ramp-up